PortfoliosLab logoPortfoliosLab logo

Amplify Weight Loss Drug & Treatment ETF (THNR) belongs to the Health & Biotech Equities category. Below you'll find alternative ETFs from the same category, ranked by key criteria, plus funds that investors commonly compare with THNR. Use the tables to find lower-cost options, better risk-adjusted returns, or a closer substitute for your current allocation.

Cheapest Alternatives to THNR

THNR charges 0.59% annually. There are 34 ETFs in the Health & Biotech Equities category with lower expense ratios, going as low as 0.08%.


Best Risk-Adjusted Alternatives to THNR

THNR has a PortfoliosLab risk / return rank of 16. There are 44 ETFs in the Health & Biotech Equities category with higher risk-adjusted ranks, going as high as 90.


Top Performing THNR Alternatives (YTD)

THNR is at -5.20% YTD. There are 45 ETFs in the Health & Biotech Equities category with higher YTD returns, going as high as 23.33%.


Lowest Volatility Alternatives to THNR

THNR has 19.15% 1-year volatility. There are 31 ETFs in the Health & Biotech Equities category with lower 1-year volatility, going as low as 0.00%.


Lowest Drawdown Alternatives to THNR

THNR has a 1-year max drawdown of -12.06%. There are 30 ETFs in the Health & Biotech Equities category with shallower 1-year drawdowns, going as shallow as 0.00%.


Other ETFs from Amplify

The 10 most viewed Amplify ETFs shown here include DIVO, QDVO, IDVO and span 10 categories. AUM among these funds goes as high as $7B.


Often Compared With THNR

Investors most often compare THNR with VOO, XHE, BBH. These 19 comparison targets span 8 categories, based on PortfoliosLab usage data.


SymbolNameCategoryRisk / Return RankYTD ReturnAUMInception
Vanguard S&P 500 ETFS&P 500
75
11.69%
1.60TSep 2010THNR vs VOO
SPDR S&P Health Care Equipment ETFHealth & Biotech Equities
7
-11.59%
128.40MJan 2011THNR vs XHE
VanEck Vectors Biotech ETFHealth & Biotech Equities
35
-3.98%
366.87MDec 2011THNR vs BBH
iShares Neuroscience and Healthcare ETFHealth & Biotech Equities
69
4.62%
5.38MAug 2022THNR vs IBRN
Virtus LifeSci Biotech Products ETFHealth & Biotech Equities
67
4.56%
78.56MDec 2014THNR vs BBP
United States Brent Oil Fund LPOil & Gas
65
86.76%
95.54MJun 2010THNR vs BNO
Global X Aging Population ETFHealth & Biotech Equities
20
-5.18%
81.82MMay 2016THNR vs AGNG
Amplify BlackSwan Growth & Treasury Core ETFDiversified Portfolio
58
5.86%
165.42MNov 2018THNR vs SWAN
iShares Commodities Select Strategy ETFCommodities
72
38.58%
1.15BOct 2014THNR vs COMT
Amplify Video Game Leaders ETFGaming
23
4.55%
40.89MMar 2016THNR vs GAMR
iShares S&P GSCI Commodity-Indexed TrustCommodities
72
41.50%
1.04BJul 2006THNR vs GSG
Invesco DB Oil FundOil & Gas
65
80.66%
275.60MJan 2007THNR vs DBO
SPDR S&P Pharmaceuticals ETFHealth & Biotech Equities
54
-0.44%
354.21MJun 2006THNR vs XPH
Invesco DB Energy FundOil & Gas
71
79.50%
99.79MJan 2007THNR vs DBE
iShares iBonds Oct 2026 Term TIPS ETFInflation-Protected Bonds
98
2.35%
85.92MSep 2023THNR vs IBIC
Invesco DB Commodity Index Tracking FundCommodities
77
34.70%
1.86BFeb 2006THNR vs DBC
F/m Emerald Life Sciences Innovation ETFHealth & Biotech Equities
68
2.73%
74.65MOct 2024THNR vs LFSC
Alpha Architect Tail Risk ETFOptions Trading
39
0.69%
668.40MAug 2013THNR vs CAOS
Simplify Propel Opportunities ETFHealth & Biotech Equities
51
7.33%
75.37MFeb 2023THNR vs SURI

Compare THNR with Any Fund or Stock

Compare THNR with any ETF, mutual fund, or stock using PortfoliosLab's comparison tool.


 

Diversifiers

Pair THNR with funds that move differently

Amplify Weight Loss Drug & Treatment ETF alternatives help with substitution. Diversifiers are the next step when you want funds with lower historical correlation to THNR.

Explore THNR Diversifiers